Caprolactam Chemicals Limited has informed the BSE of an upcoming board meeting scheduled for May 30, 2026, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting has been convened to consider, approve, and take on record the audited financial results along with the audit report of the statutory auditor for the quarter and financial year ended March 31, 2026. The intimation was filed on May 6, 2026, and has also been uploaded on the company's official website.

Board Meeting Details

The following key details pertain to the scheduled board meeting:

Trading Window Closure

In accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, the company has also disclosed the status of its trading window for dealing in its securities. The trading window has been closed effective April 1, 2026, and will remain closed until 48 hours after the public announcement of the audited financial results. This measure is in compliance with applicable insider trading regulations and is intended to restrict trading by designated persons during the period leading up to the results announcement.

Signatory Details

The board meeting intimation has been signed by Zaver Shankarlal Bhanushali, Managing Director of Caprolactam Chemicals Limited (DIN: 00663374). The communication has been addressed to BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai 400 001, and the company has requested the exchange to inform its members accordingly.

Caprolactam Chemicals Ltd has submitted a disclosure to BSE Limited regarding the non-applicability of Regulation 23(9) of the SEBI (LODR) Regulations, 2015, which mandates the disclosure of Related Party Transactions. The communication, dated April 22, 2026, was addressed to the stock exchange from Mumbai.

The company cited Regulation 15(2) of the SEBI (LODR) Regulations, 2015, which exempts listed entities from complying with corporate governance provisions under various regulations, including Regulation 23(9). This exemption applies to companies whose paid-up equity share capital does not exceed rupees ten crore and whose net worth does not exceed rupees twenty-five crore as on the last day of the previous financial year.

Financial Position as on March 31, 2025

Based on these figures, Caprolactam Chemicals Ltd confirmed that it is not required to submit Related Party Transaction disclosures as required under Regulation 23(9) of the SEBI (LODR) Regulations, 2015. The company requested BSE Limited to take this information on record.

The disclosure was signed by the Company Secretary on behalf of Caprolactam Chemicals Limited. The company's BSE code is 507486.